Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates

BACKGROUND: Alcohol use disorder (AUD) accounts for millions of acute care encounters annually in the United States. Hospitalization represents a vital opportunity to intervene pharmacologically, but low medication adherence is a significant barrier. Two single-dose, adherence-independent interventi...

Descripción completa

Detalles Bibliográficos
Autores principales: Terasaki, Dale, Loh, Ryan, Cornell, Anastasia, Taub, Julie, Thurstone, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682826/
https://www.ncbi.nlm.nih.gov/pubmed/36419181
http://dx.doi.org/10.1186/s13722-022-00345-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682826/
https://www.ncbi.nlm.nih.gov/pubmed/36419181
http://dx.doi.org/10.1186/s13722-022-00345-y

Ejemplares similares